GSK Wellbutrin XL Approval Pressures Generics to Launch SR Formulation
The approval of GlaxoSmithKline's Wellbutrin XL puts pressure on generic firms to launch their sustained-release versions of the antidepressant
The approval of GlaxoSmithKline's Wellbutrin XL puts pressure on generic firms to launch their sustained-release versions of the antidepressant